Olmesartán e Hidroclorotiazida
Nombre(s) comercial(es):
  • Benicar®HCT (como combinación de productos que contiene Hidroclorotiazida, Olmesartán)
ADVERTENCIA:
La siguiente importante información de seguridad, sobre ésta medicina, es proporcionada por el programa Alerta Médica (MedWatch) de la Administración de Alimentos y Medicamentos (FDA). Esta información no está disponible en Español, pero la versión en Inglés de la Alerta Médica está incluida para su uso.

[Posted 06/24/2014]ISSUE:FDA has completed its safety review and has found no clear evidence of increased cardiovascular risks associated with use of the blood pressure medication olmesartan in diabetic patients (see previous alerts linked below). FDA believes the benefits of olmesartan in patients with high blood pressure continue to outweigh the potential risks.

BACKGROUND:FDA safety review was prompted by the results of the ROADMAP trial. The ROADMAP (Randomized Olmesartan and Diabetes Microalbuminuria Prevention) clinical trial examined the effects of olmesartan in patients with type 2 diabetes, to see whether olmesartan could delay kidney damage. There was an unexpected finding of increased risk of cardiovascular death in the olmesartan group compared to the group taking a placebo, or sugar pill. However, the risk of non-fatal heart attack was lower in the olmesartan-treated patients. To evaluate these findings, FDA reviewed additional studies, including a large study in Medicare patients.

RECOMMENDATION:Patients should not stop taking olmesartan or any blood pressure medication without first discussing it with their health care professional. Recommendations for use of olmesartan remain the same, but FDA will require information about some of the studies to be included in the drug labels. For more information visit the FDA website at: Web Siteand Web Site.

Combinación de productos
Este producto contiene dos medicamentos,olmesartányhidroclorotiazida. Por favor, consulte las monografías individuales para obtener información sobre cada uno de los medicamentos contenidos en este producto.

AHFS® Consumer Medication Information. © Copyright, The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.

Documento actualizado: 15 Julio 2014.







Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

 

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

 

To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.